Fig. 1.
Fig. 1. NK1.1 expression on thymocytes and splenocytes from control (ZAP-70+/−) and ZAP-70−/− mice. / Thymocytes and splenocytes were stained with PE–anti-NK1.1 and FITC–anti-CD3, or FITC–anti-TCRαβ, or with PE–anti-NK1.1 and biotin–anti-TCRγδ/streptavidin-FITC. Expressions of NK1.1 (vertical) and CD3, TCRαβ, or TCRγδ (horizontal) are illustrated. Proportions of NK1.1+ CD3− and NK1.1+ CD3+ (left column), NK1.1+TCRαβ− and NK1.1+ TCRαβ+(middle column), and NK1.1+ TCRγδ−, NK1.1+ TCRγδ+, and NK1.1−TCRγδ+ (right column) cells are indicated in the figures. Results are representative of 6 independent experiments.

NK1.1 expression on thymocytes and splenocytes from control (ZAP-70+/−) and ZAP-70−/− mice.

Thymocytes and splenocytes were stained with PE–anti-NK1.1 and FITC–anti-CD3, or FITC–anti-TCRαβ, or with PE–anti-NK1.1 and biotin–anti-TCRγδ/streptavidin-FITC. Expressions of NK1.1 (vertical) and CD3, TCRαβ, or TCRγδ (horizontal) are illustrated. Proportions of NK1.1+ CD3 and NK1.1+ CD3+ (left column), NK1.1+TCRαβ and NK1.1+ TCRαβ+(middle column), and NK1.1+ TCRγδ, NK1.1+ TCRγδ+, and NK1.1TCRγδ+ (right column) cells are indicated in the figures. Results are representative of 6 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal